NCT06458244View on ClinicalTrials.gov

The Efficacy of Allo-HSCT in ND HR-CBF-AML

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

September 21, 2024

Primary Completion Date

September 20, 2026

Study Completion Date

February 29, 2028

Conditions
Acute Myeloid Leukemia
Interventions
PROCEDURE

Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation

DRUG

Chemotherapy

Chemotherapy for AML consolidation treatment

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER